Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson and Johnson reports strong gains in 1996

This article was originally published in Clinica

Executive Summary

Johnson & Johnson's professional sales rose 19.8% to $8,068 million in 1996, reflecting the company's acquisition of Cordis and the continued growth of its existing interventional cardiology product range. "We are particularly pleased to have created, in a very short period of time, a major cardiovascular business through the successful acquisition and integration of Cordis with our Interventional Systems business and its highly successful Palmaz-Schatz stent," said CEO Ralph Larsen.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel